WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the appointment of Adam Boehler as Senior Advisor for Value-Based…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on today’s hearing in the House Ways and Means Health Subcommittee…
WASHINGTON, D.C. – The MedTech Conference – North America’s premier annual gathering for medical technology executives and professionals – will again be host to the grand finals of the Medtech…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on FDA’s release of final guidance on medical device communications:
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on the introduction of legislation (HR 5997) in the U.S. House…
More than 80 Groups Unite for the First Time to Call for Legislative Reform Washington, D.C. – Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called…
Paris, France – The Global Medical Technology Alliance (GMTA), representing 26 leading international and regional medical technology associations including AdvaMed® (the Advanced Medical Technology Association®), today announced adoption of globally…
Paris, France – Bronwen Taylor, vice president, compliance and risk management at Stryker, was honored with the 2018 PwC Award for Leadership in the Advancement of Ethics in the Medical Device Industry.
Lima, Peru – The Advanced Medical Technology Association® (AdvaMed®) issued the following press release following the recent conclusion of the VIII Summit of the Americas in Lima, Peru on April…
Washington, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from President and CEO Scott Whitaker on FDA’s Medical Device Safety Action Plan: